Fam102a translocates Runx2 and Rbpjl to facilitate Osterix expression and bone formation

Area of Science:

• Bone biology and skeletal development.
• Cell differentiation and signaling pathways.
• Molecular mechanisms of bone remodeling.

Background:

• Bone remodeling is a continuous process involving osteoclasts and osteoblasts.
• Understanding common factors regulating both cell types is critical for bone health.
• Limited knowledge exists regarding shared regulatory mechanisms in osteoclast and osteoblast differentiation.

Purpose of the Study:

• To identify novel bone remodeling factors.
• To investigate the role of Family with sequence similarity 102 member A (Fam102a) in bone cell differentiation.
• To elucidate the molecular pathway involving Fam102a and Rbpjl in osteoblastogenesis.

Main Methods:

• Gene deletion and functional mutation studies in mouse models.
• Analysis of osteoclast and osteoblast differentiation markers.
• Investigation of transcription factor nuclear translocation and gene expression.
• Assessment of bone mineral density and bone formation parameters.

Main Results:

• Fam102a positively regulates both osteoclast and osteoblast differentiation.
• Fam102a controls osteoblast differentiation via the recombination signal binding protein for immunoglobulin κ J region-like (Rbpjl) axis.
• The Fam102a-Rbpjl axis promotes nuclear translocation of transcription factors and enhances Osterix expression.
• Deletion of Fam102a or Rbpjl mutation results in osteopenia with reduced osteoblastic bone formation.

Conclusions:

• The Fam102a-Rbpjl axis is a key regulator of osteoblast differentiation and bone formation.
• This pathway provides novel insights into the molecular mechanisms of bone remodeling.
• Targeting the Fam102a-Rbpjl axis may offer therapeutic potential for bone diseases.